Oncology Central

ASCO18: Preoperative chemoradiotherapy improves survival time for patients with pancreatic cancer

Research presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting held 1–5 June 2018 in Chicago (IL, USA) has highlighted the results of a randomized Phase III trial, indicating that patients who received a combination of chemotherapy with radiation (chemoradiotherapy) before surgery for pancreatic cancer had a better disease-free survival than those who started their treatment with surgery.
Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.